Creation of a Monocentric Cohort of Patients Treated for Acne at the Nantes University Hospital

ConditionAcne
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorNantes University Hospital

About this trial

With 24 million results associated with Google's searchon keywords "severe acne", Pr Dreno's team understand better thatthis disease, which affects many French people, is a real concern of Public Health and not a "forced evil" of the adolescent period, which will eventually resolve itself. Acne does not affect the vital prognosis, but its psychosocial impact is major and should not be underestimated. Paradoxically, despite the high prevalence of acne, few quality epidemiological studies have been published. Physicians are often helpless when faced with patients' questions. They often need a lot of explanations, especially on the factors aggravating this dermatosis, which greatly affects their quality of life.

This cohort, the first of its kind in France, will determine the predictive factors of therapeutic response, endogenous and environmental factors impacting on the severity of acne assess the quality of life and psychological impact of acne patients, determine the patient's course of care and the associated costs. Pr Dreno's team will also build up a bio collection (bacteriological samples).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient with acne

Patient (or parents/guardians for minors) who are not opposed to participating in the cohort.

Subjects affiliated to an appropriate health insurance

Disqualifiers

Dermatosis of the face other than acne

Refusal to participate by the minor or parent/guardian

Adults under a legal protection regime (guardianship, trusteeship, judicial safeguard)

Trial population

All patients going for the first time in specialized consultation "acne"

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • acne

    Other intervention

    Patient with acne

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Measure of Acne stage

composite criteria. the scale is GEA for Global Evaluation Acne Scale with 0 no acne to 5 severe acne

Time frame
2 years

Secondary outcomes

1

assessing patients' quality of life

composite criteria. CADI score is calculated by summing the score of each question resulting in a possible maximum of 15 and a minimum of 0. The higher the score, the more the quality of life is impaired.

Time frame
2 years
2

cost of acne illness

reimbursement data relating to hospitalizations and care in town recorded by the Health Insurance in the SNIIRAM database.

Time frame
2 years
3

Bacteriological sample to find Propionibacterium acnes, Hormonal check-up on blood sample

Correlation between bacterial and blood samples and the efficacity of the treatment

Time frame
2 years

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.